Hai Qing Hua
Fortune : - $ au 31/07/2026
Fortune : - $ au 31/07/2026
Currently, Hai Qing Hua is Executive Director at Duality Biotherapeutics, Inc. since 2026.
Formerly, Dr. Hua was Head-Biopharmaceuticals at Hansoh Pharmaceutical Group Co., Ltd. Education includes a doctorate from the University of Zurich in 2009, an undergraduate degree from Tsinghua University in 2003, and a doctorate from Columbia University Irving Medical Center.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| DUALITY BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 23/03/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
University of Zurich
University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University Medical Center
Columbia University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansoh Pharmaceutical Group Co., Ltd.
Hansoh Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells & develops pharmaceutical products | Health Technology |
Duality Biotherapeutics, Inc.
Duality Biotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-drug conjugate and therapeutics for cancer & autoimmune diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national